Latest advances in management of small cell lung cancer and other neuroendocrine tumors of the lung
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 23, 100167
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Epidemiologic trends in neuroendocrine tumors: An examination of incidence rates and survival of specific patient subgroups over the past 20 yearsSeminars in Oncology, 2018
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United StatesJAMA Oncology, 2017
- The 2015 World Health Organization Classification of Lung TumorsJournal of Thoracic Oncology, 2015
- Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to TherapyJournal of Thoracic Oncology, 2015
- Neuroendocrine Tumors of the Lung: An UpdateArchives of Pathology & Laboratory Medicine, 2010
- Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results DatabaseJournal of Clinical Oncology, 2006
- Pulmonary large-cell neuroendocrine carcinoma (LCNEC)European Journal of Cardio-Thoracic Surgery, 2003
- Pathology of small cell carcinoma of the lungSeminars in Oncology, 2003
- Phase II Study of Area Under the Plasma-Concentration-Versus-Time Curve–Based Carboplatin Plus Standard-Dose Intravenous Etoposide in Elderly Patients With Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- VP-16 and cisplatin as first-line therapy for small-cell lung cancer.Journal of Clinical Oncology, 1985